{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T06:44:52Z","timestamp":1762065892688,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.anai.2022.08.995","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:13:50Z","timestamp":1662509630000},"page":"794-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Split dosing of coronavirus disease 2019 vaccines provides noninferior antibody responsiveness to conventional vaccine dosing"],"prefix":"10.1016","volume":"129","author":[{"given":"Amal","family":"Musa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macy","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Rorie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Van De","family":"Graaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill A.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2022.08.995_bib0001","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker. 2022. Available at: https:\/\/covid.cdc.gov\/covid-data-tracker. Accessed June 6, 2022."},{"issue":"4","key":"10.1016\/j.anai.2022.08.995_bib0002","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of protection against mild and severe disease by Covid-19 vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2022.08.995_bib0003","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1056\/NEJMoa2116063","article-title":"Covid-19 vaccine effectiveness in New York State","volume":"386","author":"Rosenberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.anai.2022.08.995_bib0004","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2115624","article-title":"BNT162b2 vaccine booster and mortality due to Covid-19","volume":"385","author":"Arbel","year":"2021","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.anai.2022.08.995_bib0005","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1056\/NEJMoa2106599","article-title":"Effectiveness of mRNA Covid-19 vaccine among U.S. Health care personnel","volume":"385","author":"Pilishvili","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.anai.2022.08.995_bib0006","doi-asserted-by":"crossref","first-page":"ofab507","DOI":"10.1093\/ofid\/ofab507","article-title":"Graded administration of second dose of Moderna and Pfizer-BioNTech COVID-19 mRNA vaccines in patients with hypersensitivity to first dose","volume":"8","author":"Tuong","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.anai.2022.08.995_bib0007","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.anai.2022.02.024","article-title":"Graded coronavirus disease 2019 vaccine administration: a safe alternative to vaccine avoidance","volume":"128","author":"Pitlick","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.08.995_bib0008","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.anai.2022.05.014","article-title":"Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: the McGill University Health Centre experience","volume":"129","author":"Almuhizi","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.anai.2022.08.995_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244126","article-title":"Antibody response to SARS-CoV-2 infection in humans: a systematic review","volume":"15","author":"Post","year":"2020","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.anai.2022.08.995_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3409","article-title":"SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay","volume":"7","author":"Peluso","year":"2021","journal-title":"Sci Adv"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622017069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622017069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:31:58Z","timestamp":1761053518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622017069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1081120622017069"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.08.995","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Split dosing of coronavirus disease 2019 vaccines provides noninferior antibody responsiveness to conventional vaccine dosing","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.08.995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}